G ynecologic diseases are more frequent in HIV-infected women and are generally more severe. [1] [2] [3] [4] Among the most frequent problems are vulvovaginal candidiasis and cervical dysplasia. Other sexually transmitted diseases, pelvic inflammatory disease, genital ulcer disease, and menstrual abnormalities are also common, however. 2 HIV-infected women thus benefit greatly from routine gynecologic examinations, including a Papanicolaou smear for the screening of cervical dysplasia and cancer. Several guidelines have been elaborated with this purpose. [5] [6] [7] [8] The common denominator in the different guidelines is at least 1 annual gynecologic examination, including a Papanicolaou smear.
The primary aim of our study was to analyze whether the recommendation for at least 1 annual gynecologic examination, including a Papanicolaou smear, in HIV-positive women was followed in Switzerland and to identify factors associated with poor compliance. Further, we wanted to analyze if the implementation of questionnaires led to an increase in gynecologic visits.
METHODS

Patients
The prospective Swiss HIV Cohort Study (SHCS) follows HIV-infected individuals aged 16 years or older who attended 7 outpatient clinics specialized in infectious diseases or affiliated outpatient clinics or were seen by private physicians. It was approved by the local ethical review boards. Written informed consent was obtained from all participants. Twice a year, information on demography, HIVassociated diseases, medications, and laboratory parameters is collected. A questionnaire was introduced in April 2001 asking specifically about gynecologic visits since the last follow-up visit and whether a cervical smear had been done. 
Statistical Analysis
The Pearson x 2 test, Wilcoxon rank sum test, and a test for trend across ordered groups were used for the descriptive analysis. In addition, we performed multivariate longitudinal analyses in which the primary outcomes were ''gynecologic visit'' and Papanicolaou smear during a defined time period of 15 months. The 15-month time span was chosen because most of the study participants had 2 SHCS follow-up visits within 15 months and 2 follow-up visits were needed to assess whether the women had at least 1 yearly gynecologic visit. Therefore, the entire period during which the questionnaires were used was divided into 3 blocks of 15 months ( The analysis was conducted using longitudinal generalized estimating equations (GEEs) 9 with a logit link and an exchangeable correlation structure. , living alone, being sexually active, current intravenous drug use, current smoker, baseline follow-up in an SHCS clinic or with a private physician, CD4 cell count, HIV viral load ,400 copies/mL, previous cervical dysplasia, and the syphilis marker Treponema pallidum haemagglutination assay (TPHA). To adjust for a potential correlation of patients within the same center, we also fitted a multilevel mixed effect model with the center as a random effect.
Because some patients had only 1 SHCS follow-up visit in a time period, underreporting of gynecologic visits might have occurred. We have therefore performed a sensitivity analysis that includes only time periods with 2 visits. Estimates of associations were presented as odds ratios and 95% Wald confidence intervals.
A possible change in the proportion of patients who did not follow the recommendations was analyzed as the normal longitudinal approach, including the main predictor variable ''time since introduction of the questionnaire.'' All statistical analyses were conducted using STATA version 8.2 for Windows (Stata, College Station, TX).
RESULTS
Patient Characteristics
From April 1, 2001 to December 31, 2004, 2239 women had at least 1 follow-up visit in the SHCS, resulting in a total of 11,346 follow-up visits. Fifty-three women were excluded from the analysis because no questionnaire had been completed. The patient characteristics are shown in Table 1 . For the 53 women excluded from the analysis, ethnicity was more often not known, the proportion of intravenous drug users was higher, and they had a shorter follow-up time. There were no differences for any of the other characteristics studied.
A gynecologic examination was reported on 4594 (44.6%) of the 10,302 SHCS follow-up visits. According to the patients, no abnormality was detected in 76% of the visits, the women reported a problem in 22% of visits, and the women did not remember in 2% of visits. The median number of SHCS follow-up visits was 6 (interquartile range [IQR]: 3-7 visits), and the median number of reported gynecologic visits was 2 (IQR: 1-3 visits). From the 4594 reported gynecologic visits, 3761 (82%) women reported a Papanicolaou smear, 330 (7%) did not, it was not possible (eg, after hysterectomy) for 75 (2%), and the women did not remember if they had had a Papanicolaou smear or this information was missing in 428 (9%) cases.
A total of 1146 (52.4%) women were followed over the entire study period ($2 SHCS visits in each of the 3 time periods). Among these, 7.4% had never had a gynecologic examination, 57.3% reported an examination at 1 or 2 of the time periods, and the remaining 35.3% reported a gynecologic examination in every time period. With a Papanicolaou smear as the outcome, the corresponding proportions are 12.5%, 61.6%, and 25.9%.
There were significant differences among the 7 study sites (P , 0.001). The proportion of women who have never gone to a gynecologist varied between 2.7% and 14.1%, and the proportion with examinations reported in every time period varied between 18.5% and 59.4%. This center dependence was also confirmed in the multivariate model. Table 2 shows the patient characteristics by response pattern.
Longitudinal Analysis
The results of these analyses are shown in Figure 1 . Common predictors for fewer gynecologic examinations and Papanicolaou smears are older age, nonwhite ethnicity, less education, underweight, obesity, current intravenous drug use, current smoker, being followed by an infectious disease specialist in private practice, and no previous dysplasia. The results of the sensitivity analysis were similar, except that no significant association was found for ethnicity and intravenous drug use. In addition, women with lower CD4 cell counts were less likely to have had a gynecologic examination.
Change Over Time 
DISCUSSION
This study is consistent with previous reports from the United States demonstrating that HIV-infected women often fail to receive necessary gynecologic care. 10, 11 The fact that some reported no gynecologic care during the period studied (.3 years), despite evidence from an SHCS study showing that the incidence rate of cervical cancer in HIV-infected women is 8-fold compared with the general Swiss population, is worrisome. 12 This has important clinical and public health implications, because gynecologic diseases may be missed or diagnosed at a late stage, where treatment becomes more difficult. Extension of this problem to the Swiss population, where health care is available to all, is of note, because inability to pay is presumably not an explanation for the problem. The compulsory health insurance covers the costs of gynecologic screening irrespective of the location of the care provider. The insured has to pay only a moderate contribution.
In the SHCS, obese or underweight women, those who smoke, and those with less education are less likely to see a gynecologist, confirming previous findings. 13 The association of obesity with lack of care could be attributable to patient embarrassment or to a provider's reluctance to perform pelvic examinations.
14 Obesity and smoking have been shown to be risk factors for cervical dysplasia and cancer. 15, 16 Therefore, the association between obesity, smoking, and lack of care is of special concern.
Underweight is a negative prognostic factor in HIVinfected people 17, 18 and has multiple causes. Some of them (eg, anxiety, depression, gastrointestinal disturbances, or severe opportunistic diseases) may prevent regular gynecologic visits.
The association with less education might reflect a lack of patient knowledge about the benefits of regular care or the inability of unskilled patients to obtain needed care. 19 Smokers are probably less health conscious in general, and this might also explain why smoking was associated with less frequent gynecologic examinations.
Our results confirm that nonwhites are less likely to seek medical care. 20, 21 A previous study from the SHCS showed that taking antiretroviral therapy and disease progression were not different among patients of different ethnic groups, however. 22 Nevertheless, the situation might be different for specific types of medical care. Differences may be explained by cultural barriers and by a possible lack of knowledge among nonwhite women, 19 thus, again, proceeding in parallel with educational level.
In a previous study, 10 no relation was found for intravenous drug use, whereas this remained significant in our study, even after adjusting for smoking. We believe that this difference is related to the large number of women included in our study. Intravenous drug users are probably less interested in medical problems other than those directly related to their HIV infection and their addiction. The association with low viral load is surprising. Women with low viremia tend to be more compliant to antiretroviral therapy, suggesting a better adherence to other recommendations as well. Feeling relatively healthy, these women may think that gynecologic visits are not too important or they might spend less time discussing health problems with their infectious disease specialist.
The center dependence and the association of poor gynecologic care and a private infectious disease specialist do suggest a problem with the health care system. A short ad hoc questionnaire to the treating infectious disease specialists has shown that communication between physicians seems to be easier in hospitals (ie, they more often get copies of the screening results) and that the proportion of patients who are referred to the gynecologists varies among centers.
Nonadherence to the recommended gynecologic examinations is a general problem and is not limited to the HIV population. Many factors associated with nonadherence found in our study have been described for women who were presumably HIV-negative. 23 Other factors were related to the patient's or physician's attitude (eg, woman's perception of importance of early detection, fear of abnormal results or difficulty of coping with them, physician's opinion about Papanicolaou smear) or to the system (eg, lack of time because of child care commitments or inconvenient opening hours, male gynecologist, poor communication regarding appointments, lack of social or instrumental support). We did not have this information in our study, because women were not asked about the reasons for not going to the gynecologist. Only patients who were followed over the whole study period of 45 months in the SHCS are included (n = 1146). The P value is based on a test for trend.
Using a Papanicolaou smear instead of a gynecologic examination as the outcome, the results were similar. This is not surprising, because more than 80% of the gynecologic visits included a Papanicolaou smear.
In the sensitivity analysis, we excluded time periods with incomplete follow-up. The results obtained in this analysis were comparable to those obtained using all time periods. Despite the trend found, no significance was seen for nonwhite ethnicity, being sexually inactive, and intravenous drug use (probably because of the smaller sample size). Lower CD4 cell counts were associated with less frequent gynecologic examination visits in the sensitivity analysis only. This stands in contrast to the fact that immune-compromised women seek infectious disease specialists more often.
Change Over Time
The implementation of a questionnaire had no impact on the frequency of gynecologic visits, implying that other actions must be envisaged to improve adherence.
Frequency of Gynecologic Diseases
Fewer gynecologic examinations were associated with fewer diagnoses of cervical dysplasia and other relevant gynecologic diseases (see Table 2 ). In this study, it was not possible to establish causality, however, because no information on past gynecologic examinations was available.
Limitations
First, this questionnaire was based on the patient's capacity for remembering/willingness to report during an interview with the individual's physician or nurse, and reporting differences among patient groups may bias the results. Previous studies have shown overreporting of selfreported Papanicolaou smears. [24] [25] [26] They have asked about cervical smears within longer time periods, however, and the recall bias may thus be higher. Looking at general gynecologic examinations instead of Papanicolaou smears, the reporting accuracy was higher. 26 If overreporting existed, even more women would have inadequate gynecologic care. Second, information on why women did not see a gynecologist, why they missed appointments, and the exact frequency of gynecologic examinations could not be addressed because of a lack of documentation in the SHCS.
Third, the results cannot be readily generalized to HIVinfected women outside the SHCS, although the SHCS reflects the general Swiss HIV population well. 27 Fourth, some differences were found between the women for whom a questionnaire had been completed and those for whom it was not (see Table 1 ). Because of the high rate of completed questionnaires, however, there is little concern that this would affect the results.
CONCLUSION
Gynecologic care among HIV-positive women followed in the SHCS is not satisfactory even though all these women were followed by an infectious disease specialist. If gynecologic care does not occur, the treating physician should try to elucidate possible reasons and explain to patients why this care is so important. This could be achieved using telephone counseling, educational or motivational brochures, and appointment reminders. The infectious disease specialist could also more often refer patients (at risk) to the gynecologist.
